Myriad Genetics News
Most Popular Myriad Genetics Story
Lilly readies Phase III Alzheimer's trial
Struggling to right itself after a long dry spell in new drug approvals, Eli Lilly is preparing to a launch a late-stage study of an experimental drug for Alzheimer's. LY450139 is expected to inhibit... Read more...
Latest Headlines
- October 21, 2008
- September 11, 2008
- August 20, 2008
- June 30, 2008
- May 30, 2008
- March 31, 2008
- January 7, 2007
- July 17, 2006
- April 12, 2006
- April 10, 2006
- March 7, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
